Pacific Biosciences
PACB
₹111.91
Share price
-1.66%
Change (1 day)
-62.92%
Change (1 year)
Categories
Pacific Biosciences (PACB) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : ₹64.49 Billion
According to Pacific Biosciences 's latest financial reports the company's total liabilities are ₹64.49 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹64.67 B | -25.64% |
| 2023-12-31 | ₹86.97 B | -12.72% |
| 2022-12-31 | ₹99.64 B | 10.1% |
| 2021-12-31 | ₹90.50 B | 1476.72% |
| 2020-12-31 | ₹5.74 B | -13.51% |
| 2019-12-31 | ₹6.63 B | 68.85% |
| 2018-12-31 | ₹3.93 B | 6.17% |
| 2017-12-31 | ₹3.70 B | 2.37% |
| 2016-12-31 | ₹3.61 B | -5.47% |
| 2015-12-31 | ₹3.82 B | -13.07% |
| 2014-12-31 | ₹4.40 B | 6.32% |
| 2013-12-31 | ₹4.13 B | 272.42% |
| 2012-12-31 | ₹1.11 B | -21.75% |
| 2011-12-31 | ₹1.42 B | 22.49% |
| 2010-12-31 | ₹1.15 B | -91.02% |
| 2009-12-31 | ₹12.90 B | 30.07% |
| 2008-12-31 | ₹9.92 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | ₹336.24 B | 421.32% | 🇺🇸 USA |
 | ₹27.83 B | -56.85% | 🇺🇸 USA |
 | ₹8.861 T | 13,639.42% | 🇺🇸 USA |
 | ₹4.076 T | 6,220.73% | 🇺🇸 USA |
 | ₹565.06 B | 776.08% | 🇺🇸 USA |